Phys.org
Wednesday, October 28, 2026 at 10:00 AM1 min readVerified Wire
Engineered albumin helps a therapeutic protein last longer and cross mucosal barriers

Archived syndication image from Phys.org Direct Publisher Wire

Protein-based medicines have transformed the treatment of many diseases, but they often come with a limitation: they must be injected, sometimes repeatedly, because they are rapidly cleared from the bloodstream. For patients who depend on long-term or lifelong treatment, frequent injections place a considerable burden on everyday life.
Developing story reported by Phys.org. Further verified dispatches and detailed updates will follow shortly as confirmed by correspondents.